GO
Loading...

Enter multiple symbols separated by commas

Innovation Science

More

  • Accelerating Ebola vaccine Thursday, 4 Sep 2014 | 3:25 PM ET
    Accelerating Ebola vaccine

    CNBC's Meg Tirrell speaks to Johnson & Johnson chairman, Joaquin Duato, about J&J's partnership with the National Institutes of Health to fast track its Ebola vaccine program to begin human testing by early 2015.

  • Diabetes monitoring goes mobile Thursday, 4 Sep 2014 | 2:38 PM ET
    Diabetes monitoring goes mobile

    Discussing the new ways to monitor glucose for people with diabetes, and competition in the space, with Terry Gregg, DexCom CEO. Gregg says his business is in conversations with Apple and Samsung in regards to partnering on wearables.

  • American doctor tests for Ebola: Report Tuesday, 2 Sep 2014 | 1:00 PM ET
    American doctor tests for Ebola: Report

    CNBC's Meg Tirrell reports an American missionary doctor serving in Liberia has tested positive for Ebola.

  • Suddenly, nuclear fusion is drawing investor money Thursday, 28 Aug 2014 | 2:10 PM ET
    A Helion Energy prototype

    Two major tech investors have plowed $1.5 million into Helion Energy to help it develop a technology that hasn’t worked, according to Oilprice.com.

  • Ebola response roadmap Thursday, 28 Aug 2014 | 1:52 PM ET
    Ebola response roadmap

    GlaxoSmithKline is to begin human testing of an experimental Ebola vaccine. CNBC's Meg Tirrell reports the World Health Organization has released a response roadmap with the goal of stopping the spread of Ebola in 6 to 9 months.

  • Kite Pharma's positive cancer drug study results Wednesday, 27 Aug 2014 | 2:25 PM ET
    Kite Pharma's positive cancer drug study results

    Kite Pharma is working on a treatment which involves taking a cancer patient's own t-cells out of their body, genetically modifying them to better target cancer, and then re-administering them. Its CEO Arie Belldegrun, provides insight to the positive study with the therapy.

  • Roche's blockbuster pharma deal Monday, 25 Aug 2014 | 3:47 PM ET
    Roche's blockbuster pharma deal

    CNBC's Meg Tirrell breaks down the mega deal between Swiss pharmaceutical firm Roche and InterMune for $8.3 billion.

  • Roche CEO: InterMune perfect strategic fit Monday, 25 Aug 2014 | 11:18 AM ET
    Roche CEO: InterMune perfect strategic fit

    CNBC's Meg Tirrell speaks to Roche CEO Severin Schwan, and InterMune CEO Daniel Welch, about Roche's $8.3 billion acquisition of InterMune and the opportunity for the drug Esbriet in the U.S.

  • GPS discovers the West is so dry, it's rising Friday, 22 Aug 2014 | 4:59 PM ET
    California mountains dry lake

    California's mountains have risen more than half an inch, thanks to the absence of water to weigh them down, a study found. NBC News reports.

  • ALS raises over $13 million since July 29th Monday, 18 Aug 2014 | 6:25 AM ET
    ALS raises over $13 million since July 29th

    CNBC's Andrew Ross Sorkin looks back on some of the best ice bucket challenge videos from last week, including from Bill Gates, saying the campaign has now hit China.

  • ALS stunned by millions of dollars Friday, 15 Aug 2014 | 7:36 AM ET
    Guests on "The Tonight Show Starring Jimmy Fallon" participate in the 'Ice Bucket Challenge' on August 12, 2014.

    Lance Slaughter from the ALS Association, discusses the phenomenon spreading across social media to dump a bucket of ice over your head to raise awareness for ALS.

  • What is ALS? Friday, 15 Aug 2014 | 7:32 AM ET

    CNBC's Meg Tirrell explains what ALS, or Lou Gehrig's disease is, and what is known about treating the disease.

  • 10 economies hit hard by climate change Thursday, 14 Aug 2014 | 4:41 AM ET

    CNBC looks at which countries may be worst hit, both environmentally and economically, by climate change.

  • VOTE: Are we ready for genetically modified babies? Monday, 11 Aug 2014 | 2:44 PM ET

    Is the world ready for genetically modified babies? Here's how close we really are, explains Jessica Cussins of the Center for Genetics and Society.

  • Therapies in early development for Ebola Monday, 11 Aug 2014 | 1:07 PM ET
    Therapies in early development for Ebola

    CNBC's Meg Tirrell reports the World Health Organization has convened a panel of medical ethicists to discuss the potential treatment for Ebola patients with experimental therapies.

  • Changing compassionate use Friday, 8 Aug 2014 | 3:12 PM ET
    Changing compassionate use

    With the World Health Organization declaring Ebola an international public health emergency, CNBC's Meg Tirrell discusses the use of experimental drugs as a last resort to treat patients stricken with Ebola, cancer and other disease.

  • Tracking Ebola Friday, 8 Aug 2014 | 11:38 AM ET
    Tracking Ebola

    The World Health Organization has declared the Ebola virus an international public health emergency. CNBC's Meg Tirrell reports the details.

  • Tekmira's Ebola program gets good news Thursday, 7 Aug 2014 | 4:54 PM ET
    Tekmira's Ebola program gets good news

    The FDA has ruled to allow the potential use of drug maker Tekmira's Ebola drug on patients, reports CNBC's Meg Tirrell.

  • Is US prepared for a pandemic? Thursday, 7 Aug 2014 | 1:21 PM ET
    Is US prepared for a pandemic?

    Irwin Redlener author of "Americans at Risk," weighs in on the Ebola outbreak and discusses if the U.S. is adequately prepared to handle an epidemic.

  • Pres. Obama: Ebola can be contained if right protocols used

    President Obama discusses the Ebola outbreak, and the unproven and untested drug in the U.S. that appears to be helping infected American patients.